RxDoctor Payments Data

Ivy Altomare

Hematology & Oncology · Durham, NCNPI 1609063254

Payments from drug & device makers

$344,898in general payments, 2019–2025

Across 318 payments — averaging $1084.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$211K
  • Pfizer$62K
  • Amgen$23K
  • Novartis$20K
  • Rigel Pharmaceuticals, Inc.$20K
  • Dova Pharmaceuticals$8K
  • plus $1K from 12 others
$8,315in research payments, 2019–2025

Across 2 payments — averaging $4157.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rigel Pharmaceuticals, Inc.$8K

What the payments were for

  • Consulting fees$71,69844%
  • Speaking & faculty fees$73,38745%
  • Travel & lodging$15,63310%
  • Food & beverage$3,2342%
  • Education$120%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$344,898 in reported general payments places this provider in the 80th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina

Other hematology & oncology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →